Skip to main content
. 2021 Jan 29;56(7):1550–1557. doi: 10.1038/s41409-020-01200-x

Table 3.

Multivariate analysis.

HR SE 95% CI p value
EFS
 Age at allo-SCT
   <14years Reference
   >=14years 0.84 0.45 Jan-58 n.s.
  Gender
    Male Reference
    Female 1.18 0.68 2.06 n.s.
  Graft Type
    HLA matched Reference
    HLA mismatched 0.84 0.45 1.58 n.s.
  Disease Stage at allo-SCT
    RD Reference
    CR 0.4 0.20 0.77 0.01
OS
 Age at allo-SCT Reference
0.76 0.42 Jan-36 n.s.
  Gender
    Male Reference
    Female 1.31 0.74 2.31 n.s.
  Graft Type
    HLA matched Reference
    HLA mismatched 0.76 0.41 1.39 n.s.
  Disease Stage at allo-SCT
    RD Reference
    CR 0.29 0.15 0.57 <0.01

EFS event free survival, OS overall survival, DOD death of disease, HR, hazard ratio, SE standard error, CI confidence Interval, RD residual disease, CR complete remission, allo-SCT allogeneic stem cell transplantation, n.s. not significant.